Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.
Clinical trial NCT02554851 · UNKNOWN
Trial details
- NCT number
- NCT02554851
- Sponsor
- The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2019-12-01
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.